Patricia Eckert - 23 Feb 2024 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Financial Officer
Signature
/s/ Patricia Eckert
Issuer symbol
ENZ
Transactions as of
23 Feb 2024
Net transactions value
$0
Form type
4
Filing time
27 Feb 2024, 16:05:33 UTC
Previous filing
31 May 2023
Next filing
25 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENZ Stock Option (to acquire shares of Common Stock) Award $0 +75,000 $0.000000 75,000 23 Feb 2024 Common Stock 75,000 $1.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 75,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on February 23, 2025.